Cardiac Safety of Fingolimod 0.5 mg during the First Dose Observation in 4-Month, Open-Label, Multi-Center FIRST Study in Patients with Relapsing MS (S41.003)

Abstract only

Saved in:
Bibliographic Details
Published in:Neurology Vol. 78; no. Meeting Abstracts 1; pp. S41 - S41.003
Main Authors: Comi, G., Kappos, L., Palace, J., Gottschalk, R., Bijarnia, M., Keil, A., Tomic, D., von Rosenstiel, P., Gold, R.
Format: Journal Article
Language:English
Published: 26-04-2012
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Abstract only
ISSN:0028-3878
1526-632X
DOI:10.1212/WNL.78.1_MeetingAbstracts.S41.003